Termination status versus failure reason
A terminated clinical trial ended before its planned completion. The reason may be scientific, such as futility or safety, but it may also be practical, financial, strategic, or operational.
That distinction matters. Treating every terminated trial as a drug failure can lead to poor conclusions, especially in areas with recruitment challenges or rapidly changing standards of care.
How termination reasons are grouped
The database groups stop reasons into buckets such as efficacy/futility, safety, enrollment, funding, regulatory, strategic, operational, and other/unknown.
This makes it easier to scan large numbers of terminated records and decide which records deserve deeper primary-source review.
Using terminated trial data in research
Terminated trial patterns can inform competitive intelligence, diligence, portfolio strategy, clinical operations planning, and landscape reviews.
The most useful analyses compare termination reasons across phases, sponsors, disease areas, and interventions rather than relying on a single trial record.